Revenue Growth
For the second quarter of fiscal '26, revenue increased by 19% compared to the corresponding prior year period, reaching $3.9 million.
Improved Gross Profit
Gross profit for the quarter totaled $3.2 million, up 29.4% from the prior year period, with gross profit percentage improving by 660 basis points to 81.9%.
Positive EBITDA
The company achieved a positive EBITDA of $373,000 for the second consecutive quarter, indicating progress towards full profitability.
Advancements in Cardiac Monitoring Technology
Development of the Biocore Pro 2 cardiac monitor and expansion of Biocore Pro sales, including pilot programs with hospital networks and clinics.
Strategic Partnerships and Market Expansion
Expansion into VA and leading home care groups, as well as pulmonary and neurology partnerships.